Medtech Pharma Holdings Limited /
Pillar5 Pharma Inc.
Medtech Pharma Holdings Limited signed an agreement for Pillar5 Pharma Inc.
Source for the buyer, seller and target: Prestige Consumer Healthcare Inc.
For the buyer, seller and target.
buyer and seller
“On August 4, 2025, Medtech Pharma Holdings Limited (“Purchaser”), an Ontario corporation and a wholly-owned indirect subsidiary of Prestige Consumer Healthcare Inc. (the “Company”), entered into a definitive agreement (the “Share Purchase Agreement”) with ANJAC SAS, a French company (“ANJAC”).”
target
“The Share Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, Purchaser will acquire all of the shares of Pillar5 Pharma Inc., a Canadian company that is a leading sterile ophthalmic manufacturer and current Clear Eyes® supplier (“Pillar5”), from ANJAC for CAD 150 million in cash, subject to certain adjustments, including indebtedness, as provided in the Share Purchase Agreement (the “Transaction”).”
Published 7 Aug 2025
Open the sourceWhat happened
The deal for Pillar5 Pharma Inc. is signed, with Medtech Pharma Holdings Limited as the buyer and ANJAC SAS as the seller, at a stated price of CAD 150 million in cash. [01]
The filing from Prestige Consumer Healthcare Inc. is dated Aug. 7, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Medtech Pharma Holdings Limited signed an agreement for Pillar5 Pharma Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly